hydroxyurea has been researched along with Sclerosis, Systemic in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In two patients with Behcet's disease (BD) and rheumatoid arthritis (RA), CML developed after RD, in two patients with diffuse cutaneous systemic sclerosis and spondyloarthropathy, RD was diagnosed after CML." | 2.43 | Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature. ( Aydogdu, I; Erkurt, MA; Kaya, E; Kuku, I; Senel, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Senel, S | 1 |
| Kaya, E | 1 |
| Aydogdu, I | 1 |
| Erkurt, MA | 1 |
| Kuku, I | 1 |
| Domysławska, I | 1 |
| Ciołkiewicz, M | 1 |
| Kowal-Bielecka, O | 1 |
| Lewszuk, A | 1 |
| Klimiuk, PA | 1 |
| Sierakowski, S | 1 |
| Ramirez-Santoyo, R | 1 |
| Lopez-Swiderski, A | 1 |
| Avalos-Diaz, E | 1 |
| Herrera-Esparza, R | 1 |
1 review available for hydroxyurea and Sclerosis, Systemic
| Article | Year |
|---|---|
Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature.
Topics: Adult; Aged; Behcet Syndrome; Female; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL P | 2006 |
2 other studies available for hydroxyurea and Sclerosis, Systemic
| Article | Year |
|---|---|
[Coexistence of scleroderma-like syndrome and idiopathic myelofibrosis in a 54-year-old female patient: case report].
Topics: Antineoplastic Agents; Azathioprine; Female; Glucocorticoids; Humans; Hydroxyurea; Immunosuppressive | 2007 |
The expression and localization of Scl-70/DNA topoisomerase I vary throughout the cell cycle.
Topics: Antineoplastic Agents, Phytogenic; Autoantigens; Blotting, Western; Camptothecin; Cell Cycle; Cell D | 1998 |